Skip to main content
. 2019 Nov 19;14:9031–9046. doi: 10.2147/IJN.S223447

Figure 7.

Figure 7

Growth inhibitory activities of aTML-AgNPs-25°C against selected bacterial strains.

Notes: Growth curves of (A) S. pneumoniae, (B) S. enterica enterica, (C) H. influenza, (D) S. flexneri, (E) K. pneumoniae, and (F) S. entericaa (Salmonella enterica subsp. enterica A36 Serovar Typhimurium) after 24 hr treatment. **P < 0.01, ***P < 0.001.

Abbreviations: AgNPs, Silver nanoparticles; TM, Terminalia mantaly; aTML-AgNPs, AgNPs synthesized from aqueous leaf extracts from TM; S. pneumoniae, Streptococcus pneumoniae; S. enterica enterica, Salmonella enterica enterica; H. influenzae, Haemphilus influenzae, S. flexineri, Shigella fLexineri; K. Pneumoniae, Klebsiella pneumoniae; S. aureus, Staphylococcus aureus; S. enterica, Salmonela enterica.